NTPM’s 1HFY14 results were in line with our expectations. Sales and earnings grew 7.8% and 24.5% y-o-y respectively, mainly driven by an increase in sales of tissue products and baby diapers in the domestic market. We like the group, given its strong growth potential and upcoming expansion in Vietnam. Thus, we maintain our BUY call with a higher FV of MYR0.87 (from MYR0.73), based on 15.5x FY15F EPS.
-
On track. NTPM’s 1HFY14 revenue and net profit increased by 7.8% and 24.5% y-o-y respectively due to better performances across the board. Results were well within our expectations, representing 50% of our full-year forecast. Sales from the paper segment improved by 4% yo-y, thanks to higher demand for tissue products in the domestic market, while stronger sales of personal care products (+18.7% y-o-y) were spurred by increased demand for baby diapers. The period saw stronger PBT growth from NTPM’s paper products (+11.5% y-o-y) and personal care (+54.3%) segments. Vis-à-vis 2QFY13, sales and earnings were stronger by 7.1% and 30.3% y-o-y, buoyed by improved performance in both segments.
-
Stronger margin. EBIT and PBT margins trended higher by 1.2ppts and 1.3ppts y-o-y. Paper products’ PBT margin increased to 16.4% from 15.3% (+1.1% y-o-y), while the personal care segment saw margins rising to 10.7% from 8.2% (+2.5% y-o-y), both backed by solid sales growth.
-
Key risks. The key risks include volatile raw material prices and weaker demand. We are leaving our forecasts unchanged given that NTPM’s results were in line with our expectations.
-
Maintain BUY. We believe the group is on track to deliver satisfactory results, given its upcoming expansion into Vietnam and strong growth from its baby diapers unit. We maintain our BUY call, with our FV lifted to MYR0.87 (from MYR0.73), pegged to a higher P/E of 15.5x FY15 EPS (from 13x). The target P/E is at a 15% discount to the 18.3x weighted average P/E of its regional peers.
Financial Exhibits
SWOT Analysis
Company Profile
NTPM is principally involved in the manufacture of tissue and personal care products.
Recommendation Chart
Source: RHB